Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $2.74 -0.21 (-7.12%) As of 05/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock HSAQ vs. LUCD, INFU, ICAD, OBIO, MGRM, MBOT, GUTS, NSPR, SRTS, and INOShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include Lucid Diagnostics (LUCD), InfuSystem (INFU), iCAD (ICAD), Orchestra BioMed (OBIO), Monogram Orthopaedics (MGRM), Microbot Medical (MBOT), Fractyl Health (GUTS), InspireMD (NSPR), Sensus Healthcare (SRTS), and Inovio Pharmaceuticals (INO). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Lucid Diagnostics InfuSystem iCAD Orchestra BioMed Monogram Orthopaedics Microbot Medical Fractyl Health InspireMD Sensus Healthcare Inovio Pharmaceuticals Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment. Do analysts prefer HSAQ or LUCD? Lucid Diagnostics has a consensus target price of $3.50, indicating a potential upside of 120.13%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe Lucid Diagnostics is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Do insiders and institutionals hold more shares of HSAQ or LUCD? 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 6.8% of Lucid Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, HSAQ or LUCD? Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Does the MarketBeat Community favor HSAQ or LUCD? Lucid Diagnostics received 42 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users. CompanyUnderperformOutperformHealth Sciences Acquisitions Co. 2N/AN/ALucid DiagnosticsOutperform Votes4268.85% Underperform Votes1931.15% Does the media favor HSAQ or LUCD? In the previous week, Lucid Diagnostics had 3 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 3 mentions for Lucid Diagnostics and 0 mentions for Health Sciences Acquisitions Co. 2. Lucid Diagnostics' average media sentiment score of 0.22 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Health Sciences Acquisitions Co. 2 Neutral Lucid Diagnostics Neutral Is HSAQ or LUCD more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to Lucid Diagnostics' net margin of -1,069.87%. Company Net Margins Return on Equity Return on Assets Health Sciences Acquisitions Co. 2N/A N/A -2.38% Lucid Diagnostics -1,069.87%N/A -123.54% Which has preferable valuation and earnings, HSAQ or LUCD? Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than Lucid Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/ALucid Diagnostics$4.17M41.22-$52.67M-$1.34-1.19 SummaryLucid Diagnostics beats Health Sciences Acquisitions Co. 2 on 9 of the 14 factors compared between the two stocks. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.72M$4.38B$5.33B$8.31BDividend YieldN/A43.63%5.20%4.10%P/E RatioN/A29.0626.7219.60Price / SalesN/A73.00395.56117.96Price / CashN/A51.0838.3234.62Price / Book-4.426.186.764.50Net Income-$380,000.00$66.96M$3.23B$248.40M7 Day Performance-5.19%-1.66%0.41%-1.00%1 Month Performance-4.20%16.98%9.12%10.72%1 Year Performance-47.51%21.41%18.73%9.00% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$2.74-7.1%N/A-48.3%$30.72MN/A0.004LUCDLucid Diagnostics3.2046 of 5 stars$1.10-2.7%$3.50+218.2%+45.4%$115.92M$4.35M-0.9670Analyst DowngradeGap UpINFUInfuSystem2.454 of 5 stars$5.48+2.0%$13.00+137.2%N/A$115.17M$134.86M91.35410Positive NewsGap DownHigh Trading VolumeICADiCAD0.4355 of 5 stars$3.71+3.1%N/A+133.8%$101.83M$19.61M-28.54140News CoverageAnalyst ForecastGap DownHigh Trading VolumeOBIOOrchestra BioMed3.035 of 5 stars$2.65flat$14.20+435.8%-48.5%$101.53M$2.64M-1.654Positive NewsGap DownMGRMMonogram Orthopaedics2.931 of 5 stars$2.63-1.5%$5.40+105.3%+31.0%$92.81M$364,999.00-5.6028Gap UpMBOTMicrobot Medical1.8209 of 5 stars$2.55+1.2%$9.00+252.9%+138.0%$88.60MN/A-3.1920News CoverageEarnings ReportGap DownGUTSFractyl Health1.6606 of 5 stars$1.71+5.6%$11.00+543.3%-77.0%$79.34M$93,000.00-0.14102Gap UpNSPRInspireMD2.118 of 5 stars$2.58-0.8%$4.50+74.4%-6.1%$79.04M$7.01M-3.4450SRTSSensus Healthcare2.7264 of 5 stars$4.55+1.3%$13.00+185.7%-19.7%$75.05M$41.81M11.3840Analyst DowngradeINOInovio Pharmaceuticals3.6493 of 5 stars$1.94+7.8%$12.20+528.9%-82.0%$71.15M$217,756.00-0.49320 Related Companies and Tools Related Companies Lucid Diagnostics Competitors InfuSystem Competitors iCAD Competitors Orchestra BioMed Competitors Monogram Orthopaedics Competitors Microbot Medical Competitors Fractyl Health Competitors InspireMD Competitors Sensus Healthcare Competitors Inovio Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSAQ) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSAQ Stock Free HSAQ Stock Alerts